Prime Medicine (PRME)

• Market cap: $784M
• 1 day: 2.33%
• 5 days: -1.12%
• 1 month: -27.63%
• 3 months: 0.69%
• 6 months: 180.25%
• Year to date: 47.16%
• 1 year: 5.26%
• 5 years: -71.37%
• 10 years: -71.37%
• Sector: Healthcare
• Industry: Biotechnology

About: Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Employees: 214